GlassScriptPhysician profile
Lei Xu
NPI 1922469808
$10,382.28
in general payments reported to CMS, 2019-2025
8 companies · $147 in 2025
The $147 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $325 · 2021: $313 · 2022: $5,871 · 2023: $524 · 2024: $2,931 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,978 · Travel and Lodging: $1,456 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,978.43 |
| Travel and Lodging | $1,456.15 |
| Education | $167.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,097.72 | 2022-2023 | Cobalt Dr Mri Surescan |
| Abbott Laboratories | $3,312.15 | 2019-2025 | Aveir, Ensite, Ensite Precision |
| Medical Device Business Services, INC. | $900.24 | 2024 | Carto 3 |
| Biotronik INC. | $708.74 | 2021-2024 | Acticor 7 Vr-T Dx, Amvia Edge |
| Edwards Lifesciences Corporation | $125.62 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biosense Webster, INC. | $112.73 | 2024 | Carto 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.73 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $25.35 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lei Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.